If you would like to ask our webinar guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAccrol Gp Regulatory News (ACRL)

Share Price Information for Accrol Gp (ACRL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 38.50
Bid: 38.50
Ask: 38.70
Change: 0.05 (0.13%)
Spread: 0.20 (0.519%)
Open: 38.60
High: 38.60
Low: 38.50
Prev. Close: 38.55
ACRL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition of Severn Delta Limited

18 Jan 2024 07:00

RNS Number : 0735A
Accrol Group Holdings PLC
18 January 2024
 

 

18 January 2024

Accrol Group Holdings plc

("Accrol, the "Group" or the "Company")

 

Acquisition of Severn Delta Limited

 

Accrol (AIM: ACRL), the UK's leading independent tissue converter, is pleased to announce that the Group has completed the acquisition of Severn Delta Limited ("Severn Delta"), a £5m revenue wet wipe and tumble dryer sheet manufacturer based in Somerset, for an EBITDA multiple of less than 3x before synergies. The acquisition was funded from the Group's existing cash reserves.

 

Acquisition rationale

 

The acquisition of Severn Delta demonstrates the Group's ambition to broaden into other household products through strategic and complementary acquisitions which strengthen and extend the existing product offering. Severn Delta brings additional capacity and new capabilities to Accrol's growing wet wipe segment.

 

Severn Delta currently operates four production lines from its 33,000 sq.ft. facility in Somerset, with three lines manufacturing biodegradable personal care, household, and disinfectant wet wipes, and the other producing tumble dryer sheets.

 

As a result of the successful acquisition and integration of John Dale in April 2021 and the growth seen in the wet wipes business generally, it is clear the Group can scale the business at pace, utilising Accrol's existing relationships with UK retailers and grocers, as well as benefit from cross-selling to the new key accounts Severn Delta brings.

 

Gareth Jenkins, Chief Executive Officer of Accrol, said:

 

"We are pleased to announce the acquisition of Severn Delta and welcome its employees into the Group. Severn Delta enhances our market share in the wet wipe segment and extends our product range, adding further personal care and household wipes. The business currently operates four production lines which we believe can be utilised further to support our customers with their growth and generate a significant return on investment."

 

For further information, please contact:

 

 

Accrol Group Holdings plc

Dan Wright, Executive Chairman

Via Belvedere Communications

Gareth Jenkins, Chief Executive Officer

Chris Welsh, Chief Financial Officer

 

Zeus (Nominated Adviser & Broker) 

 

Dan Bate / Jordan Warburton

Tel: +44 (0) 161 831 1512

Dominic King

Tel: +44 (0) 203 829 5000

Shore Capital Stockbrokers (Joint Broker)

Tel: +44 (0) 20 7408 4090

Malachy McEntyre/ Mark Percy / James Thomas / Isobel Jones

 

Belvedere Communications Limited

Cat Valentine

Tel: +44 (0) 7715 769 078

Keeley Clarke

Tel: +44 (0) 7967 816 525

accrolpr@belvederepr.com

 

Overview of Accrol

 

Accrol Group Holdings plc is a leading tissue converter and supplier of toilet tissues, kitchen rolls, facial tissues, and wet wipes to many of the UK's leading discounters and grocery retailers across the UK. The Group now operates from five manufacturing sites suppling the UK tissue wet wipes market valued at over c£3.0bn at retail sales value.

 

For more information, please visit www.accrol.co.uk.

 

Link for Accrol Today video: https://www.accrol.co.uk/our-business/

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQSFFFUWELSELF
Date   Source Headline
30th Oct 201811:37 amRNSResult of AGM
30th Oct 20187:00 amRNSPDMR Dealings
29th Oct 201811:24 amRNSBoard and Board Committee Changes
10th Oct 20187:00 amRNSAppointment of Non Executive Director
28th Sep 20187:00 amRNSAudited Final Results and Notice of AGM
26th Sep 20187:00 amRNSUnaudited Final Results 2018 and Banking Update
28th Aug 20187:00 amRNSBoard and Senior Management Changes
11th Jul 20187:00 amRNSNotice of Final Results
11th Jul 20187:00 amRNSDirectorate Change
9th Jul 20184:04 pmRNSHolding(s) in Company
18th Jun 20184:39 pmRNSDirector's Dealings
18th Jun 20187:00 amRNSHolding(s) in Company
12th Jun 20183:47 pmRNSDirectors' Dealings
12th Jun 20187:00 amRNSAccrol Leads the Way with Plastic-free Packaging
11th Jun 20187:00 amRNSAppointment of Chief Financial Officer
7th Jun 20187:00 amRNSResult of Open Offer
4th Jun 20182:20 pmRNSHolding(s) in Company
4th Jun 20187:00 amRNSHolding(s) in Company
1st Jun 20188:01 amRNSDirectors' Dealings
1st Jun 20188:00 amRNSPlacing Shares Admitted and Total Voting Rights
31st May 201811:35 amRNSResult of General Meeting
22nd May 20186:25 pmRNSPosting of Cricular
22nd May 20187:00 amRNSOpen Offer
22nd May 20187:00 amRNSTR1
15th May 20185:16 pmRNSPosting of Circular
15th May 20183:08 pmRNSProposed Placing to raise £8 million
3rd May 20187:00 amRNSHolding(s) in Company
1st May 20182:06 pmRNSSecond Price Monitoring Extn
1st May 20182:00 pmRNSPrice Monitoring Extension
1st May 20187:00 amRNSRevised Banking Arrangements & Operational Update
4th Apr 20185:06 pmRNSDirector Shareholding
29th Mar 20183:26 pmRNSTR1: Standard form
29th Mar 20187:00 amRNSTR-1: Standard form
27th Mar 20183:43 pmRNSStatement re Share Price Movement
26th Mar 20184:41 pmRNSSecond Price Monitoring Extn
26th Mar 20184:35 pmRNSPrice Monitoring Extension
21st Mar 201812:32 pmRNSHolding(s) in Company
19th Mar 20187:00 amRNSTrading Update
15th Feb 20185:55 pmRNSDirector/PDMR Shareholding
13th Feb 20187:00 amRNSDirector/PDMR Shareholding
8th Feb 20184:31 pmRNSDirector/PDMR Shareholding
5th Feb 20187:00 amRNSBoard Changes
23rd Jan 20181:16 pmRNSPDMR Dealings
22nd Jan 20187:01 amRNSInterim Results for six months ended 31 Oct 2017
22nd Jan 20187:00 amRNSBoard Change
17th Jan 20183:25 pmRNSUpdate on Health and Safety Incident
4th Jan 20187:00 amRNSTR-1: Standard form
3rd Jan 20187:00 amRNSNotice of Half Year Results
13th Dec 201710:57 amRNSHolding(s) in Company
12th Dec 20177:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.